CYTS_HUMAN - dbPTM
CYTS_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CYTS_HUMAN
UniProt AC P01036
Protein Name Cystatin-S
Gene Name CST4
Organism Homo sapiens (Human).
Sequence Length 141
Subcellular Localization Secreted .
Protein Description This protein strongly inhibits papain and ficin, partially inhibits stem bromelain and bovine cathepsin C, but does not inhibit porcine cathepsin B or clostripain. Papain is inhibited non-competitively..
Protein Sequence MARPLCTLLLLMATLAGALASSSKEENRIIPGGIYDADLNDEWVQRALHFAISEYNKATEDEYYRRPLQVLRAREQTFGGVNYFFDVEVGRTICTKSQPNLDTCAFHEQPELQKKQLCSFEIYEVPWEDRMSLVNSRCQEA
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
7Phosphorylation-MARPLCTLLLLMAT
-CCHHHHHHHHHHHH
28.29-
21PhosphorylationTLAGALASSSKEENR
HHHHHHHCCCCCCCC
35.6722817900
23PhosphorylationAGALASSSKEENRII
HHHHHCCCCCCCCCC
41.411898055
35PhosphorylationRIIPGGIYDADLNDE
CCCCCCCCCCCCCHH
14.35-
63PhosphorylationNKATEDEYYRRPLQV
HCCCCCHHHHHHHHH
18.00-
119PhosphorylationLQKKQLCSFEIYEVP
HHHCCCCEEEEEECC
34.211898055
132PhosphorylationVPWEDRMSLVNSRCQ
CCHHHHHHHHHHHHH
30.021898055
136PhosphorylationDRMSLVNSRCQEA--
HHHHHHHHHHHCC--
27.271898055

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of CYTS_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CYTS_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CYTS_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CYTS_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Confident assignment of intact mass tags to human salivary cystatinsusing top-down Fourier-transform ion cyclotron resonance massspectrometry.";
Ryan C.M., Souda P., Halgand F., Wong D.T., Loo J.A., Faull K.F.,Whitelegge J.P.;
J. Am. Soc. Mass Spectrom. 21:908-917(2010).
Cited for: PHOSPHORYLATION AT SER-21 AND SER-23, DISULFIDE BONDS, TISSUESPECIFICITY, SUBCELLULAR LOCATION, AND MASS SPECTROMETRY.
"The effects of human salivary cystatins and statherin onhydroxyapatite crystallization.";
Johnsson M., Richardson C.F., Bergey E.J., Levine M.J.,Nancollas G.H.;
Arch. Oral Biol. 36:631-636(1991).
Cited for: PROTEIN SEQUENCE OF 21-36, AND PHOSPHORYLATION AT SER-23.
"Identification of full-sized forms of salivary (S-type) cystatins(cystatin SN, cystatin SA, cystatin S, and two phosphorylated forms ofcystatin S) in human whole saliva and determination of phosphorylationsites of cystatin S.";
Isemura S., Saitoh E., Sanada K., Minakata K.;
J. Biochem. 110:648-654(1991).
Cited for: PROTEIN SEQUENCE OF 21-36, AND PHOSPHORYLATION AT SER-21 AND SER-23.
"Large-scale purification and characterization of the majorphosphoproteins and mucins of human submandibular-sublingual saliva.";
Ramasubbu N., Reddy M.S., Bergey E.J., Haraszthy G.G., Soni S.-D.,Levine M.J.;
Biochem. J. 280:341-352(1991).
Cited for: PROTEIN SEQUENCE OF 21-55, AND PHOSPHORYLATION AT SER-23.

TOP